Plasma ET-1 has been associated with the development of endothelial dysfunction [4], and it has been reported that the production and function of ET-1 and its receptors are upregulated in a number of disease states associated with endothelial dysfunction, including hypertension and atherosclerosis [5–8]. Here, EDN1 is linked to atherosclerosis.